Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer

Gynecologic Oncology

Volumn 115, Issue 1, 2009, Pages 108-111

  Folkins, Ann K ^a   Saleemuddin, Aasia ^a   Garrett, Leslie A ^b   Garber, Judy E ^a   Muto, Michael G ^b   Tworoger, Shelley S ^a   Crum, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Gynecologic Oncology   (United States)

Author keywords

Cortical inclusions; Endosalpingiosis; Mullerian; Ovarian cancer; Tubal ligation

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BODY MASS; CANCER RISK; COHORT ANALYSIS; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; ONCOGENE; OVARY CARCINOMA; OVARY CYST; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SALPINGOOOPHORECTOMY; TUMOR SUPPRESSOR GENE; UTERINE TUBE LIGATION;

ADULT; CARCINOMA, ENDOMETRIOID; FALLOPIAN TUBE NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; OVARIAN CYSTS; OVARIAN NEOPLASMS; OVARIECTOMY; PELVIC NEOPLASMS; RISK FACTORS; YOUNG ADULT;

EID: 69249216425     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.06.032     Document Type: Article

References (32)

1. Zajicek J. Ovarian cystomas and ovulation, a histogenetic concept. Tumori 63 (1977) 429-435
2. Fathalla M.F. Incessant ovulation-a factor in ovarian neoplasia?. Lancet 2 (1971) 163
3. Scully R.E., Young R.H., and Clement P.B. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament (1998), Atlas of Tumor Pathology, AFIP 6-7
4. Singer G., Kurman R.J., Chang H.W., Cho S.K., and Shih I.e.M. Diverse tumorigenic pathways in ovarian serous carcinoma. Am. J. Pathol. 160 (2002) 1223-1228
5. Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 9 (2008) 1191-1197
6. Brewer M.A., Johnson K., Follen M., Gershenson D., and Bast Jr. R. Prevention of ovarian cancer: intraepithelial neoplasia. Clin. Cancer Res. 9 (2003) 20-30
7. Cai K.Q., Klein-Szanto A., Karthik D., Edelson M., Daly M.B., Ozols R.F., et al. Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. Gynecol. Oncol. 103 (2006) 719-728
8. Tok E.C., Ertunc D., Tataroglu C., Yazici G., Kanat H., and Dilek S. Clinicopathologic study of the putative precursor lesions of epithelial ovarian cancer in low-risk women. Int. J. Gynecol. Cancer. 16 2 (2006) 501-506
9. Saleemuddin A., Folkins A.K., Garrett L., Garber J., Muto M.G., Crum C.P., et al. Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations. Gynecol. Oncol. 111 (2008) 226-232
10. Almonte M., Albero G., Molano M., Carcamo C., García P.J., and Pérez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 26 Suppl. 11 (2008) L16-L36
11. Lee Y., Miron A., Drapkin R., Nucci M.R., Medeiros F., Saleemuddin A., et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 211 (2007) 26-35 Erratum in: J Pathol. 2007 Sep;213(1):116
12. Heller D.S., Hameed M., and Baergen R. Lack of proliferative activity of surface epithelial inclusion cysts of the ovary. Int. J. Gynecol. Cancer 13 (2003) 303-307
13. Salazar H., Godwin A.K., Daly M.B., Laub P.B., Hogan W.M., Rosenblum N., et al. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J. Natl. Cancer Inst. 88 (1996) 1810-1820
14. Mittal K.R., Zeleniuch-Jacquotte A., Cooper J.L., and Demopoulos R.I. Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. Int. J. Gynecol. Pathol. 12 (1993) 59-63
15. Seidman J.D., and Wang B.G. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma. Gynecol. Oncol. 106 (2007) 201-206
16. Casey M.J., Bewtra C., Hoehne L.L., Tatpati A.D., Lynch H.T., and Watson P. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. Gynecol. Oncol. 78 (2000) 278-287
17. Barakat R.R., Federici M.G., Saigo P.E., Robson M.E., Offit K., and Boyd J. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer 89 (2000) 383-390
18. La Vecchia C., Decarli A., Franceschi S., Regallo M., and Tognoni G. Age at first birth and the risk of epithelial ovarian cancer. J. Natl. Cancer Inst. 73 (1984) 663-666
19. Whiteman D.C., Siskind V., Purdie D.M., and Green A.C. Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol. Biomark. Prev. 12 (2003) 42-46
20. Merrill R.M., Fugal S., Novilla L.B., and Raphael M.C. Cancer risk associated with early and late maternal age at first birth. Gynecol. Oncol. 96 (2005) 583-593
21. Leitzmann M.F., Koebnick C., Danforth K.N., Brinton L.A., Moore S.C., Hollenbeck A.R., et al. Body mass index and risk of ovarian cancer. Cancer 115 (2009) 812-822
22. Olsen C.M., Nagle C.M., Whiteman D.C., Purdie D.M., Green A.C., and Webb P.M. Australian Cancer Study (Ovarian Cancer) and Australian Ovarian Cancer Study Group. Body size and risk of epithelial ovarian and related cancers: a population-based case-control study. Int. J. Cancer 123 2 (2008 Jul 15) 450-456
23. Schouten L.J., Rivera C., Hunter D.J., et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol. Biomark. Prev. 17 4 (2008 Apr) 902-912 Epub 2008 Apr 1.
24. Beehler G.P., Sekhon M., Baker J.A., Teter B.E., McCann S.E., Rodabaugh K.J., et al. Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr. 136 11 (2006 Nov) 2881-2886
25. Niwa Y., Yatsuya H., Tamakoshi A., et al. JACC Study. Relationship between body mass index and the risk of ovarian cancer in the Japanese population: findings from the Japanese Collaborate Cohort (JACC) study. Group Obstet. Gynaecol. Res. 31 5 (2005 Oct) 452-458
26. Zhang M., Xie X., and Holman C.D. Body weight and body mass index and ovarian cancer risk: a case-control study in China. Gynecol. Oncol. 98 2 (2005 Aug) 228-234
27. Engeland A., Tretli S., and Bjørge T. Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J. Natl. Cancer Inst. 95 16 (2003 Aug 20) 1244-1248
28. Huusom L.D., Frederiksen K., Høgdall E.V., Glud E., Christensen L., Høgdall C.K., et al. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study. Cancer Causes Control 17 6 (2006 Aug) 821-829
29. Riman T., Dickman P.W., Nilsson S., Correia N., Nordlinder H., Magnusson C.M., et al. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol. Oncol. 83 3 (2001 Dec) 575-585
30. Sorosky J.I. Endometrial cancer. Obstet. Gynecol. 111 (2008) 436-447
31. Kurian A.W., Balise R.R., McGuire V., and Whittemore A.S. Histologic types of epithelial ovarian cancer: have they different risk factors?. Gynecol. Oncol. 96 (2005) 520-530
32. Finch A., Shaw P., Rosen B., Murphy J., Narod S.A., and Colgan T.J. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol. Oncol. 100 (2006) 58-64